Multi-center evaluation of the fully automated PCR-based Idylla™ KRAS mutation assay for rapid KRAS mutation status determination on formalin-fixed paraffin-embedded tissue of human colorectal cancer
<p>Since the advent of monoclonal antibodies against epidermal growth factor receptor (EGFR) in colorectal cancer therapy, the determination of RAS mutational status is needed for therapeutic decision-making. Most prevalent in colorectal cancer are <em>KRAS</em> exon 2 mutations (4...
প্রধান লেখক: | Solassol, J, Vendrell, J, Märkl, B, Haas, C, Bellosillo, B, Montagut, C, Smith, M, O'Sullivan, B, D'Haene, N, Le Mercier, M, Grauslund, M, Melchior, L, Burt, E, Cotter, F, Stieber, D, Schmitt, F, Motta, V, Lauricella, C, Colling, R, Soilleux, E, Fassan, M, Mescoli, C, Collin, C, Pagès, J, Sillekens, P |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
Public Library of Science
2016
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
অনুযায়ী: Jérôme Solassol, অন্যান্য
প্রকাশিত: (2016-01-01) -
Spatial heterogeneity of KRAS mutations in colorectal cancers in northern France
অনুযায়ী: Turpin A, অন্যান্য
প্রকাশিত: (2019-09-01) -
KRAS Mutation in Serous Borderline Tumor of the Testis: Report of a Case and Review of the Literature
অনুযায়ী: Sarah Bouri, অন্যান্য
প্রকাশিত: (2020-01-01) -
KRAS mutations and endometriosis burden of disease
অনুযায়ী: Natasha L Orr, অন্যান্য
প্রকাশিত: (2023-07-01) -
Clinical Significance of the KRAS Mutation
অনুযায়ী: Sead Beganovic
প্রকাশিত: (2010-10-01)